Literature DB >> 1988675

Structure, function and properties of antibody binding sites.

I S Mian1, A R Bradwell, A J Olson.   

Abstract

Do antibody combining sites possess general properties that enable them to bind different antigens with varying affinities and to bind novel antigens? Here, we address this question by examining the physical and chemical characteristics most favourable for residues involved in antigen accommodation and binding. Amphipathic amino acids could readily tolerate the change of environment from hydrophilic to hydrophobic that occurs upon antibody-antigen complex formation. Residues that are large and can participate in a wide variety of van der Waals' and electrostatic interactions would permit binding to a range of antigens. Amino acids with flexible side-chains could generate a structurally plastic region, i.e. a binding site possessing the ability to mould itself around the antigen to improve complementarity of the interacting surfaces. Hence, antibodies could bind to an array of novel antigens using a limited set of residues interspersed with more unique residues to which greater binding specificity can be attributed. An individual antibody molecule could thus be cross-reactive and have the capacity to bind structurally similar ligands. The accommodation of variations in antigenic structure by modest combining site flexibility could make an important contribution to immune defence by allowing antibody binding to distinct but closely related pathogens. Tyr and Trp most readily fulfil these catholic physicochemical requirements and thus would be expected to be common in combining sites on theoretical grounds. Experimental support for this comes from three sources, (1) the high frequency of participation by these amino acids in the antigen binding observed in six crystallographically determined antibody-antigen complexes, (2) their frequent occurrence in the putative binding regions of antibodies as determined from structural and sequence data and (3) the potential for movement of their side-chains in known antibody binding sites and model systems. The six bound antigens comprise two small different haptens, non-overlapping regions of the same large protein and a 19 amino acid residue peptide. Out of a total of 85 complementarity determining region positions, only 37 locations (plus 3 framework) are directly involved in antigen interaction. Of these, light chain residue 91 is utilized by all the complexes examined, whilst light chain 32, light chain 96 and heavy chain 33 are employed by five out of the six. The binding sites in known antibody-antigen complexes as well as the postulated combining sites in free Fab fragments show similar characteristics with regard to the types of amino acids present. The possible role of other amino acids is also assessed.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988675     DOI: 10.1016/0022-2836(91)90617-f

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  109 in total

1.  Molecular structure of eight human autoreactive monoclonal antibodies.

Authors:  I Aguilera; J Melero; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F(ab) and F(c) fragments.

Authors:  A W Vermeer; W Norde; A van Amerongen
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis.

Authors:  R Norel; F Sheinerman; D Petrey; B Honig
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

4.  Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.

Authors:  Ralph Pantophlet; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Structural requirements of the major protective antibody to Haemophilus influenzae type b.

Authors:  L Hougs; L Juul; A Svejgaard; T Barington
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.

Authors:  J Tormo; E Stadler; T Skern; H Auer; O Kanzler; C Betzel; D Blaas; I Fita
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

7.  In vitro selection of an RNA epitope immunologically cross-reactive with a peptide.

Authors:  D E Tsai; D J Kenan; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

8.  Molecular determinants for antibody binding on group 1 house dust mite allergens.

Authors:  Maksymilian Chruszcz; Anna Pomés; Jill Glesner; Lisa D Vailes; Tomasz Osinski; Przemyslaw J Porebski; Karolina A Majorek; Peter W Heymann; Thomas A E Platts-Mills; Wladek Minor; Martin D Chapman
Journal:  J Biol Chem       Date:  2011-12-30       Impact factor: 5.157

9.  Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.

Authors:  Robyn L Stanfield; Ian A Wilson; Vaughn V Smider
Journal:  Sci Immunol       Date:  2016-07-14

Review 10.  The importance of handling high-value biologicals: Physico-chemical instability and immunogenicity of monoclonal antibodies.

Authors:  Tomislav Laptoš; Jasna Omersel
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.